Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women?

Physiol Res. 2008:57 Suppl 1:S153-S157. doi: 10.33549/physiolres.931500. Epub 2008 Feb 13.

Abstract

Osteoprotegerin (OPG) plays an important inhibitory role in osteoclastogenesis. Polymorphisms in the OPG gene recently have been associated with various bone phenotypes including fractures. The aim of the present study was to investigate the association between three informative OPG polymorphisms and quantitative ultrasound variables of the heel. In a cohort of 165 perimenopausal women polymorphisms in the OPG promoter (A163G, T245G) and in exon 1 (G1181C) were assessed by PCR-RFLP analysis. The distribution of the investigated genotypes was similar to other Caucasian women (A163G-AA 68 %, AG 30 %, GG 2 %, T245G-TT 84.4 %, TG 15 %, GG 0.6 %, G1181C- GG 22 %, CG 55 %, CC 23 %). After adjustment for body mass index and years since menopause, in a subgroup of 87 postmenopausal subjects, calcaneal velocity of sound (VOS, m/s) was significantly associated with A163G polymorphism (p=0.0102, ANCOVA). Women with the presence of G allele (AG+GG genotypes) had significantly lower VOS than women with AA genotype. Neither T245G nor G1181C were associated with calcaneal ultrasound indices. In conclusion, A163G polymorphism was significantly associated with VOS at the heel in a limited cohort of postmenopausal women. The present study replicated in part the previous findings about OPG gene variations and peripheral bone mass in Caucasian women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Calcaneus / diagnostic imaging*
  • Calcaneus / physiology*
  • Cohort Studies
  • Female
  • Genotype
  • Humans
  • Middle Aged
  • Osteoprotegerin / genetics*
  • Phenotype
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length
  • Postmenopause / genetics*
  • Promoter Regions, Genetic / genetics
  • Ultrasonography
  • White People

Substances

  • Osteoprotegerin
  • TNFRSF11B protein, human